7 Days
Source:
Los Angeles Times
_1777370220974_847775619.png&w=48&q=75){kind=small}
Obesity drugs show promise for PMOS treatment
Charlotte Touzalin and her mother, Anne Schultz, were diagnosed with polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affecting insulin and testosterone levels. Recent research indicates that GLP-1 medication treatments can improve symptoms such as weight loss, hormone balance, and ovulation in women with PMOS. Despite promising results from studies, insurance coverage remains a barrier, limiting access to these treatments.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)